In patients

In patients new product with septic shock [8] or severe sepsis and coma [9] the prevalence may reach up to 100%. In the majority of patients with sepsis a combination of both CIP and CIM was described [10].Independent risk factors for CIPNM are, amongst others, severity of illness, duration of MOF with or without SIRS, duration of vasopressor and catecholamine support, hyperglycemia and duration of intensive care unit (ICU) stay [1].The clinical features of CIP and CIM are almost identical and include muscle weakness and atrophy primarily of the lower limbs and respiratory muscles, delayed weaning from the respirator not explained by pulmonary or cardiovascular findings, and prolongation of the mobilization phase [1]. Moreover, a number of complications, such as pneumonia, deep vein thrombosis and pulmonary embolism may be attributed – at least in part – to CIPNM [11].

On neurological examination, decreased or absent tendon reflexes, especially with CIP, muscular atrophies and symmetrical flaccid tetraparesis are present [1].The gold standards used to diagnose CIPNM are electrophysiological stimulation (EPS) and muscle biopsy. Characteristically, electromyography (EMG) and nerve conduction velocity (NCV) studies demonstrate the preservation of the speed of impulse in the presence of decreased compound muscle (CMAP) and sensory nerve (SNAP) action potential amplitudes [12]. These findings are highly consistent with a relatively pure axonal polyneuropathy. Furthermore, EMG discloses signs of denervation like fibrillation potentials and positive sharp waves in a widespread distribution.

For the definite diagnosis of CIM and to differentiate between CIP and CIM the histological assessment of a muscle biopsy is the preferable method [1].For CIPNM no specific pathogenic-based therapy is proven. For prevention, sepsis should be treated with maximum effort, including intensive insulin therapy (IIT) [13]. Muscle relaxants and corticosteroids should be administered at the lowest doses needed, whereas the potentially detrimental effect of the latter has been controversially discussed [14].However, there is weak evidence from a retrospective chart analysis of prospectively collected data, that early IgM-enriched IVIG application may prevent CIPNM [15].IVIG contains natural polyreactive antibodies derived from human plasma of healthy donors directed against endogenous and exogenous antibodies, immunomodulating peptides and various cytokines [16].

The pathophysiologic rationale for using IVIG to treat CIPNM is based on the Anacetrapib association of CIPNM with pro-inflammatory cytokines accompanied by increased E-selection expression [3,17]. This favors the accumulation of neurotoxic factors in the endoneurium and causes extravasation of activated leukocytes both resulting in neuron damage [18].

Samples were centrifuged at 3500 rpm for 10 minutes at 4��C and p

Samples were centrifuged at 3500 rpm for 10 minutes at 4��C and plasma was collected and stored frozen at -80��C until assaying. IL-6 and TNF-�� were this site measured in duplicate using a commercially available ELISA kit (Biosource, CA, USA). The sensitivities of the assays were 3 pg/ml for IL-6 and 3 pg/ml for TNF-�� and 3 pg/ml for IL-6.Western blot methodologyAt the end of the experimental period (nine hours for western blot experiments) spleens were harvested (n = four per group). The samples of spleen were then homogenized (Polytron homogenizer by Kinematica, Bethlehem, PA, USA) in ice-cooled lysis buffer (20 mm Tris-HCl, 150 mm NaCl, 1 mm Na2DTA, 1 mm EGTA, 1% Triton, 2.5 mm sodium pyrophosphate, 1 mm ��-glycerophosphate, 1 mm Na3VO4, 2 mm dl-dithiothreitol, 1 mm phenylmethanesulfonyl, and 1 ��g/ml leupeptin; pH 7.

5) and centrifuged at 3000 g for 10 minutes at 4��C. The supernatant was further centrifuged twice, initially at 12,000 g for 15 minutes at 4��C and a second time at 20,000 g for 45 minutes at 4��C. The protein concentration of supernatant was determined with the Bradford protein assay (Bio-Rad, Herts, UK). The supernatant (10 ��g protein per sample) were denaturated in NuPAGE LDS Sample buffer (Invitrogen, Paisley, UK) at 70��C for 10 minutes and then were loaded on a NuPAGE 4 to 12% Bis-Tris Gel (Invitrogen, Paisley, UK). After electrophoresis, the proteins were electrotransferred to a nitrocellulose membrane (Hybond ECL; Amersham Biosciences, Buckinghamshire, UK) and incubated with a blocking solution composed of 5% fat dry milk in Tween-containing Tris-buffered saline (pH 8.

0, 10 mm Tris, 150 mm NaCl, 0.1% Tween). The blocked membrane was incubated overnight at 4��C with the cleaved caspase-3 antibody (New England Biolab, Hitchin, United Kingdom). After washing with Tween-containing Tris-buffered saline for four times, the membrane was incubated for one hour at room temperature with the appropriate horseradish peroxidase-conjugated secondary antibody directed at the primary antibody. The bands were then visualized with enhanced chemiluminescence (New England Biolab, Hitchin, United Kingdom) and exposed onto Hyperfilm ECL film (Amersham Biosciences, Buckinghamshire, United Kingdom). Subsequently, the membrane was re-probed with caspase 3 and beta-action primary antibody respectively and the rest procedures were repeated again as above.

The band density was analyzed densitometrically and normalized with the housekeeping protein beta-actin and then presented as percentage of control.Mortality rateAnimals Batimastat were monitored every two hours via video recording of the animal in its cage following the initial eight-hour sedative infusion period and animal mortality was noted (n = 10 per group). After 16 hours of follow up (i.e., 24 hours post CLIP) all animals were sacrificed by lethal sodium pentobarbital injection.

Table S3 is a table that lists the adjusted logistic regression m

Table S3 is a table that lists the adjusted logistic regression model to evaluate the association between mean arterial blood pressure (MAP), mean vasopressor load and 28-day mortality.Click here for file(40K, DOC)NotesSee selleck 17-AAG related commentary by Jones et al., http://ccforum.com/content/14/1/102
In a previous edition of Critical Care, Shorr and colleagues developed a simple weight risk score for identifying patients with candidemia upon hospital admission [1]. Using recursive partitioning, they determined the best discriminators of Candida bloodstream infections in patients upon hospitalization (identified as a positive blood culture 1 day prior to or 2 days after admission) by retrospectively reviewing the CareFusion Outcomes Research Database, comprising 64,109 bloodstream infection cases admitted to 176 acute care hospitals from 2000 to 2005.

Three sets of models were applied (equal weight, unequal weight, and full weight with additional variables) for sensitivity analysis. The risk score was then validated using the 2006/2007 year cohort for a total of 24,685 bloodstream infections.The rate of candidemia was 1.2% of all bloodstream infections for the 5-year derivation cohort, and was 1.3% for the validation cohort. The rate was increased to 2.3% and 3.1%, respectively, for those patients with mechanical ventilation. Baseline characteristics were largely similar between both cohorts, and univariate analysis determined that the following risk factors are associated with candidemia: age ��64 years; cachexia; deranged albumin, arterial pH, and electrolytes; temperature ��98��C or fever; altered mental status; previous hospitalization within 30 days; admission from another healthcare facility; and mechanical ventilation.

Recursive partitioning revealed that the six best discriminators are age <64 years, temperature <98��C, cachexia, previous hospitalization, admission from another healthcare facility, and mechanical ventilation.In the derivation cohort, those patients with one risk factor had a rate of candidemia of 0.4% while those with all six risk factors had a rate of 27.3%. In the validation cohort, the rates of candidemia were similar through the risk factor stratification groups. The area under the receiver operating curve for the risk score was 0.70 for the derivation cohort and was 0.71 for the validation cohort.

With the model involving six risk factors, the area under the receiver operating curve was similar in Entinostat both cohorts. Finally, the area under the receiver operating curve for the model with 16 risk factors was associated with a slightly higher discrimination in both cohorts; but on recalibration with the validation cohort, seven risk variables were deemed poor discriminators – thus suggesting that additional factors did not improve the risk model during validation.

The authors comment

The authors comment enzyme inhibitor that nausea, vomiting, and sialorrhea generally improved after modificating their technique to a double plication. Two patients presented with upper GI bleeding a few weeks after discharge. They were treated with endoscopic hemostasis. Two patients returning with general abdominal discomfort were found to have microleaks which were treated conservatively. Four patients had to be reoperated. One patient presented with portomesenteric thrombosis an the 24th postoperative day. The authors comment that portomesenteric thrombosis is a rare but serious complication of all laparoscopic operations, probably attributed to venous stasis due to pneumoperitoneum and anti-Trendelenburgs position [17]. The patient had jejunal necrosis and underwent jejunectomy.

1 patient was reoperated for gastric obstruction due to prolapse of the gastric fold, while two had accumulation of serous fluid within the cavity of the plication. These final cases led to the modification of their technique with creation of a double plication, thus creating smaller multiple gastric folds with less probability of both prolapse and accumulation of fluid. Mortality was zero. This is a very interesting study, the largest in literature so far, with relatively good medium term followup. The results on %EWL are similar to those achieved with LSG. Major complication rate is quite low (2.9%) and resulted in no mortality. The authors have presented a new modification to the standard technique of LGCP which could bear many benefits.

Unfortunately they appear to be using the new technique in all new cases, instead of randomizing them in two groups of single-fold and multiple-fold technique. In any case, results presented in this study are very good with %EWL rates similar to those achieved with LSG for the 24 month follow-up period and low complication rates. Long-term follow-up results should be interesting. Andraos et al. published a series of 120 cases [10]. Mean operative time was 65 minutes (45�C90 minutes) and mean hospital stay was 36 hours (24 to 120). Most patients were discharged in 24 hours. There was one conversion due to intraoperative bleeding. Followup is very short, of only six months. Mean TWL in 1, 3 and 6 months is reported at 11.2kg, 16kg, and 23kg, respectively, whereas %EWL at the same time is reported at 30.2% at 1 month, 43.9% at 3 months, and 48.58% at 6 months. No Batimastat conclusions can be drawn on the effectiveness of LGCP from this study so far. Medium- and long-term follow-up results should prove useful. What makes this publication interesting is the very detailed description of complications.

In addition, it seems that the indication for robotic thyroidecto

In addition, it seems that the indication for robotic thyroidectomy can be expanded to include advanced thyroid cancer, because lymph node resection can be performed with great dexterity, removing a similar number of lymph nodes as in open surgery. Other groups have reported selleckchem Ivacaftor slight modifications to this technique. Tae et al. [55] inserted the 4th arm trocar through an ipsilateral periareolar nipple incision, while Lee et al. [56] used a bilateral transaxillary approach with CO2 insufflation. In any case, these techniques were shown to be feasible and have comparable results to open surgery, although CO2 insufflation has been associated with increased probability of pneumomediastinum and air embolism [57] Table 2. Table 2 Major clinical series in robot-assisted thyroidectomy. 7.4.

Robot-Assisted Parathyroidectomy Technically similar to the surgery performed for thyroidectomy, robot-assisted parathyroidectomy was described in 2004 by Bodner et al. [59�C62]. This technique involves a 5-to-6cm vertical skin incision in the axilla with a subcutaneous skin flap created from the axilla to the anterior neck area over the pectoralis major muscle and clavicle under direct vision. An external retractor attached to a lifting device maintains the working space. A second 0.8cm skin incision is made on the anterior chest. With these 2 incisions, 4 robotic arms can be inserted��3 in the axilla and 1 in the anterior chest wall. Following this study, other publications detailed further robot-assisted parathyroidectomy [63�C69]. The most recent and largest study Tolley et al.

included 11 patients with hyperparathyroidism [70]. This study showed that the robot-assisted surgery allowed adequate visualization of important anantomicanatomic structures in this region, good resection, and a hospital length of stay comparable to nonrobotic minimally invasive surgeries [71�C77]. Only one case needed to be converted to open surgery due to the patient’s large body habitus��a factor shown to be a predictor of longer operative times [70]. Validated questionnaires regarding quality of life and cosmetic appearance showed good subjective results for this new approach. 7.5. Skull Base Surgery The fundamental studies that established the technical Dacomitinib feasibility of TORS to gain access to many regions, such as the oral cavity, oropharynx, hypopharynx, and larynx, raised the question about whether the robot can reach more difficult places. TORS used in skull base surgery was initially assessed by O’Malley Jr. and Weinstein [78], using animal and cadaver models. They also reported the first human case��a patient that underwent resection of parapharyngeal cystic neoplasm extending into the infratemporal fossa. Overall there were no adverse surgical events.

In their recent study, Stevens et al have shown a reverse trend

In their recent study, Stevens et al. have shown a reverse trend in their stroke rate (3.4%��sternotomy approach, 1.2%��videoscopic approach, and 0.7%��robotic mitral valve procedures) [49]. 6. Bleeding Related Complications Transfusion of allogenic red blood http://www.selleckchem.com/products/Sunitinib-Malate-(Sutent).html cells (RBCs) is recognized as a risk factor for adverse outcome after cardiac surgery [50]. Unnecessary transfusions are likely to be associated with unnecessary morbidity and additional indirect hospitalization costs. Throughout the last decade, one of the major benefits of MIMVS has been claimed to be the less bleeding related complications and less usage of blood products [38, 51�C54] as compared to the conventional sternotomy approach. Other authors have shown no difference in blood requirements in the two different groups [55].

In a recent study, Gammie et al. [48] could not show any difference in reexploration for bleeding in the MIMVS group when compared to the traditional sternotomy group but have shown a statistically significant higher use of perioperative red blood cell (52.6% for the open group and 41% for the MIMVS group) and platelet (25.3% for the open group and 15.8% for the MIMVS group) transfusion. However, when these outcomes were risk aadjusted there was no significant difference in the transfusion of either red blood cell or platelet [48]. Stevens et al. published their recent data with no difference in reexploration for bleeding in the three groups of conventional, videoscopic, and robotic mitral valve surgery (series of 2,255 patients) but with a significant difference in the requirement of blood transfusion (63%��conventional group, 43%��videoscopic, and 18%��robotic mitral valve procedures) [49].

7. Postoperative Atrial Fibrillation (AF) There are conflicting data in the literature regarding the incidence of AF following MIMVS. It has been suggested that a less traumatic surgical approach would be a less potent trigger of postoperative AF. Five of six studies, however, demonstrated this not to be the case [11, 56�C60], and on meta-analysis of four eligible studies, there was no significant difference between minimally invasive and sternotomy approaches (539 patients, OR 0.86, 95% CI 0.59�C1.27, P = 0.45). More recently Gammie et al. [48], however, have shown a decreased incidence of postoperative AF (20.1% for the conventional sternotomy group and 15.

9% for the less invasive group). 8. Septic Complications The incidences of septic complications and wound infections are less in thoracotomy than with sternotomy. Of the three studies of mini-thoracotomy mitral valve surgery that reported wound complications compared to median Entinostat sternotomy, Grossi et al. reported an incidence of 0.9% and 5.7% for mini-thoracotomy and sternotomy cases, respectively (P = 0.05) [61]. This increased to 1.8% and 7.7%, respectively, in elderly patients (P = 0.03) [37]. Santana et al.

This would be the pre dicted relationship in a lateral inhibition

This would be the pre dicted relationship in a lateral inhibition system, where a Notch inhibitor Belinostat al positive feedback loop would amplify the Notch activity differences between neighboring cells. Two additional transcription factors that have been previously shown to be involved in leg morphogenesis were found to promote Notch signaling, Bonus, a homologue of the vertebrate TIF1beta transcriptional cofactor, and crooked legs, a zinc finger pro tein. Notch signaling is known to play an important role in Drosophila leg development, and the recovery of these two transcription factors as modifiers of Notch induced E m3 expression suggests that bon and croI may function to modulate Notch target gene output in the developing leg. We also identified the Drosophila orthologues of two mammalian proto oncogenes kayak, and c Myb, as positive regulators of Notch signaling.

Although a direct functional link between these proteins and Notch signaling has not been described, kayak has been shown to interact genetically with Hairless and c Myb genetically interacts with bon, a novel Notch modifier described above. In addition, our data reveals a synergistic relationship between the positive regulator of Ras signaling, 14 3 3��, and Notch. Once again, the pro tein interaction network shows extensive contacts between 14 3 3�� and the chromatin machinery, suggest ing a mechanism for modulating Notch target transcrip tion through Su mediated chromatin modifications. Interactions between Notch and oncogenic pathways are of particular interest, as the involvement of Notch in cancer biology and stem cell maintenance is becoming increasingly apparent.

An unexpected Notch target transcription modifier identified in the screen is the Notch target gene Tram track. We found that targeting of ttk with dsRNA resulted in reduced Notch activity. In contrast, ttk expression itself has been shown to increase in response to ectopic Notch activity. The RNAi treatment data suggest that ttk may function in a posi tive feedback mechanism to promote Notch activated transcription and the network analysis suggests that this interaction may be mediated by a direct contact with Notch itself. Conclusions A complementary, genome wide RNAi approach has revealed a subset of factors that modulate Notch target transcription that may not have been found by tradi tional genetic approaches. For instance, pleiotropic effects combined with non saturating mutagenesis Brefeldin_A may have obscured the detection of some components in tra ditional genetic screens. Several novel modifiers were identified in this RNAi transcription based screen, and these factors will be further investigated for their precise roles in the regulation of Notch signaling during devel opment.

our we

pathway signaling This process gives rise to cells with extra copies of chromosomes, permitting amplification of the genome in specialized cells. In humans, these include hepatocytes, cardiomyocytes and megakaryocytes. In C. elegans, two tissues are polyploid, the hypo dermis and the intestine. Our finding of co expres sion of SAC genes in these tissues may suggest a possible role of these genes in the process of endoredu plication in C. elegans. Furthermore, our findings clearly suggest that SAC genes are differentially regulated at the transcription level at different developmental stages. Conclusion We have examined for the first time in vivo spatiotem poral expression profiles of eight conserved spindle assembly checkpoint genes in C. elegans.

Our compre hensive analysis revealed that all of the SAC gene pro moters displayed common early embryonic activities in the majority, if not all, of the rapidly dividing embryonic cells. Furthermore, we found that all of the SAC gene promoters drive tissue specific postembryonic expres sion. The expression patterns differ between the SAC genes, the majority of the SAC genes co express in hypodermal seam cells and gut cells. These findings sug gest that the SAC components may have distinct roles in postembryonic development which could be different from their role in mitosis. Furthermore, our analysis provides an important starting point for analysis of the checkpoint roles in development of a multicellular eukaryote that may offer explanation for distinct pheno typic consequence upon inactivation of different SAC eration, cell fate determination and cell differentiation in a multicellular organism.

Methods C. elegans strains, alleles and culturing The Bristol strain N2 was used as the standard wild type strain. The following mutant alleles were used in this work, dpy 5, mdf 1, mdf 2, ced 3, unc 26, lin 35, fzr 1 and fzy 1. The wls51 strain JR667 was used to visualize the seam cell nuclei in wild type worms and the mutant backgrounds. The strains were obtained from the Caenorhabditis Genetics Center unless otherwise stated. The following transgenic strains were generated, JNC104, JNC105, JNC106, JNC107, JNC108, JNC109, JNC110, JNC111, JNC112, JNC113, JNC114, JNC115 , JNC116, JNC117. Animals were maintained using standard procedures. Generation of pSAC,GFP transgenic animals The promoter,GFP constructs were generated using the PCR stitching technique.

The PCR experi ments were designed to amplify and fuse 5 sequence immediately upstream of the predicted ATG initiator site for a targeted gene to an adjacent upstream gene. All of the primers were designed semi Brefeldin_A manually with the aid of primer3 and used in standard PCR pro cedures to amplify putative SAC gene promoters from C. elegans N2 single worm lysates. These amplicons were then fused to the PCR products con taining gfp sequence and unc 54 3UTR from pPD95. 75. For fusion PCR reactions we used Phusion high fidelity DNA polymerase.

The HNa uty software is freely available, the source code is pro

The HNa uty software is freely available, the source code is pro vided as Additional files 1 and 2. Its functionality can also be accessed from within BioNetGen. Methods Graphical formalism underlying the BioNetGen Language The model specification language BNGL has evolved over time and has been described in selleck chemicals Ganetespib detail. It is based on a graphical formalism described initially by We are now ready to introduce the two types of graphs in the BNGL formalism that are of interest here. A molecular entity graph is a labeled graph together with a map that assigns to each vertex a list of possible attributes. A chemical species graph is derived from a molecular entity graph or a collection of connected molecular entity graphs such that all variable attributes take on specific values.

Thus, molecular entity graphs model the types of molecules in a reaction network and chemical species graphs model specific chemical species, which are composed of molecules. These two types of graphs can be encoded in a machine readable form according to the conventions of BNGL. As should be apparent from the above definitions, in models speci fied using BNGL, all components of proteins are considered structurally equivalent. Thus, the graphs of BNGL can potentially obscure the struc tural relationships among the component parts of a protein. Two examples of proteins with hierarchical substructures Here, we discuss two examples of proteins with hierarch ical substructures, meaning that functional components in these proteins have subcomponents.

Figure 1A depicts the human lymphocyte cell specific protein tyrosine kinase, which is a Src family non receptor tyrosine kinase that plays an important role in T cell receptor signaling. As can be seen, Lck is composed of one SH3 domain, one SH2 domain, Faeder et al. and then more formally and in greater detail by Blinov et al. The formalism includes various types of graphs, two of which are rele vant for our purposes, the molecular entity graph and the chemical species graph. Let us recall the basic defi nition of a graph. A graph is a pair where is a finite set and is a collection of pairs of vertices. A simple graph is a graph in which there is at most one edge between any two vertices. If this condition does not hold and the graph has multiple edges between at least one pair of vertices, then the graph is a multi graph.

All graphs are assumed to be simple unless otherwise noted. If a graph is directed, then the edges are AV-951 ordered pairs, otherwise they are unordered. A labeled graph is a graph together and one PTK domain. The tyrosine residues of Lck represented in Figure 1A have been shown to be phosphorylated during TCR signaling. Phosphorylation of Y192 in the SH2 domain of Lck reduces the ability of the SH2 domain to bind its phospho tyrosine containing binding sites in other proteins.

MC were e posed to patho physiologic Hcy concentration that has b

MC were e posed to patho physiologic Hcy concentration that has been pre viously shown to modulate MC behaviour. The results sellectchem revealed that several cytokines were sig nificantly affected by this manoeuvre, including TIMP 1, MIP 2, interferon gamma and fractalkine. MIP 2 influ ences leukocyte migration and has been shown to mediate inflammatory infiltration in glomerular disease. Accordingly, we chose to e plore the influence of Hcy on MIP 2 and to relate the observations to leukocyte interac tion with glomerular MC in an in vitro assay system. Homocysteine induces MIP 2 e pression and increases MIP 2 protein Initially we determined the influence of variable Hcy con centrations on MIP 2 e pression by qRT PCR. The results indicated a significant impact on e pression at 50 and 100 M.

Another sulphur containing amino acid, that is structurally similar to DL Hcy did not influence e pression. Hence changes in MIP 2 e pression can be attributed to an effect specific to Hcy, rather than to structural similari ties with L Cys. Subsequently, the e pression of MIP 2 induced by Hcy in MC was quantified by western blot analysis. In line with the e pression data, Hcy significantly increased MIP 2 protein levels in MC. Of note, MIP 2 e pression increased 2. 5 fold at 50 MHcy, com pared to e pression at 100 M L Cys. MIP 2 lev els did not increase further when Hcy concentration was increased to 100 M. Homocysteine induced MIP 2 requires p38MAPK and PI3kinase but not P42 44 MAPK Signaling MIP 2 induction has been reported to be MAPK and PI 3 Kinase dependent.

Hence, we investigated role of MAPK and PI 3 Kinase in MIP 2 e pression induced by Hcy. Hcy induced MIP 2 was significantly attenuated by a PI 3 Kinase inhibitor and by an inhibitor of a p38MAPK. In contrast, use of a p42 44 MAPK inhibitor did not significantly alter Hcy induced MIP 2. Immunohistochemistry was employed as another analyt ical tool to e amine the effect of Hcy on mesangial MIP 2. Cells were e posed to Hcy, in the absence and presence of inhibitors to p38MAPK and PI3 Kinase. MIP 2 e pression in medium supplemented with FBS and L Cys represented control condi tions. As revealed in figure 2, panel C, the e pression of MIP 2 was increased by Hcy compared to control. Hcy induced of MIP 2 was abolished by LY294002 and SB203580.

These results suggest that Hcy induced e pression of MIP 2 in MC was mediated by p38MAPK and PI 3 K signalling pathways and are consist ent with the results derived from Western blotting analy sis. Hcy activates p85 PI 3 Kinase and p38MAPK in mesangial cells In an effort to corroborate the observations related to blunting of the effect of Hcy on MIP 2 by inhibitors of PI3 Kinase and p38MAPK, western blotting analyses was employed to determine levels of activated p38MAPK and PI3 Kinase in Carfilzomib MC e posed to ele vated levels of e tracellular Hcy. Hcy induced time dependent increases in p38 MAPK phosphorylation between 10 and 30 minutes.